SEATTLE — June 23, 2026 — Fred Hutch Cancer Center announced eight recipients of this year’s Dr. Eddie Méndez Scholar Award. The annual award recognizes the work of exceptional early-career scientists ...

Our liver cancer researchers and clinicians work together to translate discoveries from the lab into new options for patients. Many also care for patients, allowing them to quickly move promising ...

Eight Fred Hutch researchers receive nearly $1 million to advance projects with industry partnership potential SEATTLE — July 14, 2026 — Eight researchers at Fred Hutch Cancer Center will receive a ...

Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...

Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential SEATTLE — June 16, 2025 — Nine researchers at Fred Hutch Cancer Center will ...

If you have breast cancer, you are in good hands at Fred Hutchinson Cancer Center. Our experts care for people with all types and stages of the disease. More than that, we are leaders in preventing ...

We can meet with you in person or remotely, whichever you prefer. This service is provided to all current Fred Hutch patients, caregivers and family members. Deciding to quit tobacco is an important ...

Save the Date - May 9-12, 2027 at the Grand Hyatt, Seattle, WA The 6th Symposium on Infectious Diseases in the Immunocompromised Host will bring together leaders and trainees in research and clinical ...

At Fred Hutch Cancer Center, our team of internationally recognized multiple myeloma experts are dedicated to providing you with the best care possible. Your physician will create a personalized ...

The CSRN is a multi-center effort, funded by the National Cancer Institute, and is the first large-scale network to focus on cancer screening. Fred Hutch Cancer Center serves as the coordinating and ...

Immunotherapy trailblazer Dr. Stanley Riddell reflects on the science, setbacks and breakthroughs that helped transform T cells into powerful cancer treatments.